Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Wireless Telecom Group Announces First Quarter 2019 Financial Results

Published

on

Reading Time: 11 minutes

Highlights for the quarter ended March 31, 2019:

  • Net revenues of $13,032,000, reflecting growth in two of three
    segments
  • Gross Profit of $5,727,000, or 43.9%
  • Net loss of $344,000
  • Non-GAAP Adjusted EBITDA of $354,000
  • New Customer orders of $12,387,000
  • March 31, 2019 backlog of firm orders of $7,575,000
  • Decrease in S,G&A, increase in R&D to drive future growth
  • Company announces target revenues of $100 million by 2023,
    inclusive of acquisitions

PARSIPPANY, N.J.–(BUSINESS WIRE)–Wireless Telecom Group, Inc. (NYSE American: WTT) (the “Company”)
announced today results for the 2019 first quarter ended March 31, 2019.

Tim Whelan, CEO of Wireless Telecom Group, Inc., commented, “Our Q1
financial results were as we expected exiting 2018 which was a record
year for the Company. Revenue was comparable to last year’s Q1 and
yielded margins reflecting our revenue product mix of lower software and
more hardware cards. We are pleased with continued top-line strength in
Embedded Solutions and the year over year increase in Network
Solutions.” Whelan added, “We are excited about our R&D investments and
the product initiatives we released during the first quarter across
multiple segments which included product collaboration on LTE eNodeB
software, our product launch for real-time public safety monitoring, and
our launch of noise sources for 5G test systems.”

Whelan continued, “We continue to invest for long-term growth and remain
optimistic for continued momentum throughout the remainder of 2019. We
are on track for our long-term target of $100 million in revenue,
consisting of strong organic growth and strategic acquisitions, while
improving profitability and cash flows.”

For the quarter ended March 31, 2019, the Company reported consolidated
net revenues of $13,032,000, compared to $13,264,000 for the same period
in 2018, a decrease of 1.7%. Network Solutions revenue increased 4.5% on
increased large venue projects and customized solutions and Embedded
Solutions revenue increased 6.4% on higher sales of digital signal
processing hardware. This was offset by a decrease of 19.5% in Test and
Measurement revenue on lower government shipments compared to the same
quarter last year, which are expected to increase over the coming
quarters.

The Company also reported consolidated gross profit of $5,727,000, or
43.9% of revenue, for the quarter ended March 31, 2019, compared to
$6,268,000 or 47.3% of revenue, for the same period in 2018. The decline
in gross profit margin was due to a higher mix of lower margin hardware
sales at Embedded Solutions and the impact of competitive pricing in the
Network Solutions industry which were partially offset due to a
favorable product mix in Test and Measurement.

For the quarter ended March 31, 2019, the Company reported consolidated
operating expenses of $6,125,000, compared to $5,700,000 for the same
period in 2018, an increase of $425,000. The increase was driven by our
investments in research and development in the area of 5G roadmap
development and was offset by a 3% decline of sales, marketing, general
and administrative expenses.

The net loss for the quarter ended March 31, 2019 was $344,000, compared
to net income of $374,000 for the same period in 2018.

Non-GAAP Adjusted EBITDA for the quarter ended March 31, 2019 was
$354,000, compared to $1,612,000 for the same period in 2018. The
decrease in non-GAAP Adjusted EBITDA from the prior year is attributable
to the decrease in gross profit as described above coupled with the
increased investments in research and development. The Company’s
explanation of Adjusted EBITDA and the reconciliation of Adjusted EBITDA
to net income (loss) is set out below in this press release.

The Company’s consolidated backlog of firm orders to be shipped in the
next twelve months was $7,575,000 at March 31, 2019, compared to the
March 31, 2018 backlog of $10,576,000.

Outlook

Near term, the Company expects revenues for the second quarter of 2019
to slightly increase compared to the same quarter last year and gross
margins to be comparable. The Company also maintains the expectation for
full year 2019 revenues to grow organically in the low to mid-single
digits, with full-year gross margins comparable to last year. A strict
focus on driving operational leverage is expected to generate
profitability and cash flow growth at rates higher than expected revenue
growth. The Company’s principal considerations for full-year 2019
expectations include slower than anticipated deployment of 5G
infrastructure, judicious investment in R&D and new product development
while controlling operating expenses, and uncertainty around the timing
of select, large and new customer opportunities in the funnel.

Beyond 2019, the Company expects to grow revenues organically between 10
and 12% over the next four years based on the long term trends of
network densification and 5G deployment, private LTE network expansion
and increased military spend. In addition, the Company also expects
strong organic growth to be driven by multiple internal initiatives
including the continuation of new product introductions, channel
expansion, and operational excellence. The Company’s 2023 targets also
include annual revenues of $100 million, inclusive of strategic
acquisitions, gross profit margins between 47% and 49%, and Adjusted
EBITDA margins of approximately 15%. The Company defines Adjusted EBITDA
margins as Adjusted EBITDA divided by revenue (see use of Non-GAAP
Financial Measures below).

Conference Call

As previously announced, Wireless Telecom Group Inc. will host a
conference call today at 8:30 a.m. ET in which management will discuss
first quarter results and related matters. To participate in the
conference call, dial 800-346-7359 or 973-528-0008. The conference
identification number is 762201. The call will also be webcast over the
internet at the following URL: https://www.webcaster4.com/Webcast/Page/1690/30414

A replay will be made available on the Wireless Telecom website for a
limited period of time following the conference call.

Use of Non-GAAP Financial Measures

The Company reports its financial results in accordance with generally
accepted accounting principles (“GAAP”). Management believes, however,
that certain non‐GAAP financial measures used in managing the Company’s
business may provide users of this financial information with additional
meaningful comparisons between current results and prior reported
results. Certain of the information set forth herein and certain of the
information presented by the Company from time to time may constitute
non‐GAAP financial measures within the meaning of Regulation G adopted
by the Securities and Exchange Commission. We have presented herein a
reconciliation of these measures to the most directly comparable GAAP
financial measure. The non‐GAAP measures presented herein may not be
comparable to similarly titled measures presented by other companies.
The foregoing measures do not serve as a substitute and should not be
construed as a substitute for GAAP performance, but provide supplemental
information concerning our performance that our investors and we find
useful.

The Company defines EBITDA as its net earnings before interest, taxes,
depreciation and amortization. “Adjusted EBITDA” is EBITDA excluding our
stock compensation expense, restructuring charges, acquisition expenses,
integration expenses, the one-time non-cash inventory impairment
charges, unrealized and realized foreign exchange gains and losses, and
other non-recurring costs and includes cash received in 2018 related to
revenue that would have been recognized in 2018 but for the adoption of
ASU Topic 606. A reconciliation of net income to non-GAAP Adjusted
EBITDA is included as an attachment to this press release.

The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by
revenue. The Company does not provide a forward-looking reconciliation
of expected Adjusted EBITDA Margin as the amount and significance of
special items required to develop meaningful comparable GAAP financial
measures cannot be estimated at this time without unreasonable efforts.
These special items could be meaningful.

The Company views Adjusted EBITDA and Adjusted EBITDA margin as
important indicators of performance, consistent with the manner in which
management measures and forecasts the Company’s performance. We believe
Adjusted EBITDA and Adjusted EBITDA margin are important performance
metrics because they facilitate the analysis of our results, exclusive
of certain non‐cash items, including items which do not directly
correlate to our business operations.

The Company believes that Adjusted EBITDA and Adjusted EBITDA margin
metrics provide qualitative insight into our current performance and we
use these measures to evaluate our results. Additionally, we use
Adjusted EBITDA to measure the performance of our management team and
management’s entitlement to incentive compensation. We believe that
making this information available to investors enables them to view our
performance the way that we view our performance and thereby gain a
meaningful understanding of our core operating results, in general, and
from period to period.

Forward-Looking Statements

This press release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. In some
cases, such forward-looking statements may be identified by terms such
as believe, expect, seek, may, will, intend, project, anticipate, plan,
estimate, guidance or similar words. Forward-looking statements include,
among others, statements regarding expectations for revenue and gross
margins for the quarter ending June 30, 2019 and the year ending
December 31, 2019, expectations for increased government shipments in
the remaining quarters of 2019; expectations for improved profitability
and cash flow for the year ending December 31, 2019; expectations
relating to long-term growth, including long-term revenue expectations
of$100 million; long-term organic revenue growth rates, gross profit
margins and Adjusted EBITDA margins. Investors are cautioned that such
forward-looking statements are not guarantees of future performance and
involve a number of risks and uncertainties that could materially affect
actual results, including, among others, the ability of management to
successfully implement the Company’s business plan and strategy; the
loss of any significant customers of the Company; the Company’s ability
to acquire accretive businesses and successfully integrate acquired
businesses; product demand and development of competitive technologies
in the Company’s market sector; the impact of competitive products and
pricing; as well as other risks and uncertainties set forth in the
Company’s Annual Report on Form 10-K for the year ended December 31,
2018. These forward-looking statements speak only as of the date of this
release and the Company does not undertake any obligation to update or
revise any forward-looking information to reflect changes in
assumptions, the occurrence of unanticipated events, or otherwise, as
except as required by law.

About Wireless Telecom Group, Inc.

Wireless Telecom Group, Inc., comprised of Boonton Electronics,
CommAgility, Microlab and Noisecom, is a global designer and
manufacturer of advanced radio frequency and microwave components,
modules, systems and instruments. Serving the wireless,
telecommunication, satellite, military, aerospace, semiconductor and
medical industries, Wireless Telecom Group products enable innovation
across a wide range of traditional and emerging wireless technologies.
With a unique set of high-performance products including peak power
meters, signal analyzers, signal processing modules, LTE PHY and stack
software, power splitters and combiners, GPS repeaters, public safety
monitors, noise sources, and programmable noise generators, Wireless
Telecom Group supports the development, testing, and deployment of
wireless technologies around the globe. Wireless Telecom Group is
headquartered in Parsippany, New Jersey, in the New York City
metropolitan area, and maintains a global network of Sales and Service
offices for excellent product service and support. Wireless Telecom
Group’s website address is http://www.wtcom.com.

 

Wireless Telecom Group Inc.
CONSOLIDATED STATEMENT
OF OPERATIONS AND COMPREHENSIVE INCOME/(LOSS)

(In
thousands, except per share amounts, Unaudited)

 
    Three Months Ended
March 31

2019

 

2018

NET REVENUES $ 13,032 $ 13,264
 
 
COST OF REVENUES   7,305       6,996  
 
 
GROSS PROFIT 5,727 6,268
 
Operating Expenses
Research and Development 1,714 1,157
Sales and Marketing 1,937 1,910
General and Administrative   2,474       2,633  
Total Operating Expenses 6,125 5,700
 
 
Operating Income/(Loss) (398 ) 568
 
 
Other Income/(Expense) 31 (46 )
Interest Expense   (115 )     (92 )
 
Income/(Loss) before taxes (482 ) 430
 
 
Tax Provision/(Benefit) (138 ) 56
 
     
Net Income/(Loss) $ (344 )   $ 374  
 
 
Other Comprehensive Income/(Loss):
Foreign Currency Translation Adjustments   305       579  
Comprehensive Income/(Loss) $ (39 )   $ 953  
 
 
 
Earnings/(Loss) Per Share:
Basic $ (0.02 ) $ 0.02
Diluted $ (0.02 ) $ 0.02
 
 
Weighted Average Shares Outstanding:
Basic 20,973 20,644
Diluted 20,973 21,633
 

In periods with a net loss, the basic loss per share equals the diluted
loss per share as all common stock equivalents are excluded from the per
share calculation because they are anti-dilutive.

 
 

CONSOLIDATED BALANCE SHEET
(In thousands, except
number of shares and par value)

 
    March 31   December 31
2019 2018
(Unaudited)
CURRENT ASSETS
Cash & Cash Equivalents $ 2,457 $ 5,015
Accounts Receivable – net of reserves of $62 and $44, respectively 12,129 8,638
Inventories – net of reserves of $1,830 and $1,910, respectively 7,763 6,884
Prepaid Expenses and Other Current Assets   1,017       1,689  
 
TOTAL CURRENT ASSETS 23,366 22,226
 
 
PROPERTY PLANT AND EQUIPMENT – NET 2,517 2,578
 
 
OTHER ASSETS
Goodwill 9,950 9,778
Acquired Intangible Assets, net 3,001 3,206
Deferred Income Taxes 5,751 5,592
Right Of Use Lease Asset 1,766
Other Assets   738       787  
 
TOTAL OTHER ASSETS 21,206 19,363
 
     
TOTAL ASSETS $ 47,089     $ 44,167  
 
 
CURRENT LIABILITIES
Short Term Debt $ 4,051 $ 2,016
Accounts Payable 5,215 3,252
Short Term Lease Liability 423
Accrued Expenses and Other Current Liabilities 2,967 6,083
Deferred Revenue   207       103  
 
TOTAL CURRENT LIABILITIES 12,863 11,454
 
 
LONG TERM LIABILITIES
Long Term Lease Liability 1,350
Other Long Term Liabilities 96 115
Deferred Tax Liability   628       616  
TOTAL LONG TERM LIABILITIES 2,074 731
 
 
COMMITMENTS AND CONTINGENCIES
 
 
SHAREHOLDERS’ EQUITY
Preferred Stock, $.01 par value, 2,000,000 shares authorized, none
issued
Common Stock, $.01 par value, 75,000,000 shares authorized,
34,488,852 and 34,393,252
shares issued, 21,300,252 and 21,205,251 shares outstanding 345 344
Additional Paid in Capital 48,687 48,479
Retained Earnings 7,212 7,556
Treasury Stock at Cost, 13,188,601 and 13,188,601 shares,
respectively
(24,509 ) (24,509 )
Accumulated Other Comprehensive Income   417       112  
TOTAL SHAREHOLDERS’ EQUITY 32,152 31,982
     
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 47,089     $ 44,167  
 
 

CONSOLIDATED STATEMENT OF CASH FLOWS
(In thousands,
unaudited)

 
    For the Three Months
Ended March 31
2019   2018
 
CASH FLOWS USED BY OPERATING ACTIVITIES
Net Income/(Loss) $ (344 ) $ 374
Adjustments to reconcile net income/(loss) to net cash used by
operating activities:
Depreciation and Amortization 549 626
Amortization of Debt Issuance Fees 16 19
Share-based Compensation Expense 209 188
Deferred Rent (6 ) 5
Deferred Income Taxes (159 ) 37
Provision for Doubtful Accounts 18 (1 )
Inventory Reserves 47 19
Changes in Assets and Liabilities, Net of Acquisition:
Accounts Receivable (3,456 ) (1,574 )
Inventories (916 ) (524 )
Prepaid Expenses and Other Assets 792 (507 )
Accounts Payable 1,888 (255 )
Payment of Contingent Consideration (772 )
Accrued Expenses and Other Liabilities   (1,235 )     635  
Net Cash Used by Operating Activities   (3,369 )     (958 )
 
CASH FLOWS USED BY INVESTING ACTIVITIES
Capital Expenditures (128 ) (199 )
Acquisition of Business, Net of Cash Acquired   (426 )     (811 )
Net Cash Used by Investing Activities   (554 )     (1,010 )
 
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES
Revolver Borrowings 9,788 10,603
Revolver Repayments (7,715 ) (9,191 )
Term Loan Repayments (38 ) (38 )
Payment of Contingent Consideration (782 )
Proceeds from Exercise of Stock Options         288  
Net Cash Provided by Financing Activities   1,253       1,662  
 
Effect of Exchange Rate Changes on Cash and Cash Equivalents 112 88
NET DECREASE IN CASH AND CASH EQUIVALENTS (2,558 ) (218 )
 
Cash and Cash Equivalents, at Beginning of Period   5,015       2,458  
 
CASH AND CASH EQUIVALENTS, AT END OF PERIOD $ 2,457     $ 2,240  
 
SUPPLEMENTAL INFORMATION:
Cash Paid During the Period for Interest $ 41 $ 36
Cash Paid During the Period for Income Taxes $ 26 $ 9
 
 

NET REVENUE AND GROSS PROFIT BY SEGMENT
(In
thousands, Unaudited)

 
    Three months ended March 31
Revenue   % of Revenue   Change
2019   2018   2019   2018   Amount   Pct.
Network Solutions $ 5,758   $ 5,511   44.2 %   41.5 %   $ 247   4.5 %
Test and Measurement 3,030 3,763 23.3 % 28.4 % (733 ) -19.5 %
Embedded Solutions   4,244     3,990   32.6 %   30.1 %     254     6.4 %
Total Net Revenues $ 13,032   $ 13,264   100.0 %   100.0 %   $ (232 )   -1.7 %
 
 
 
Three months ended March 31
Gross Profit   Gross Profit %   Change
2019   2018   2019   2018   Amount   Pct.
Network Solutions $ 2,389 $ 2,442 41.5 % 44.3 % $ (53 ) -2.2 %
Test and Measurement 1,569 1,845 51.8 % 49.0 % (276 ) -15.0 %
Embedded Solutions   1,769     1,981   41.7 %   49.6 %     (212 )   -10.7 %
Total Gross Profit $ 5,727   $ 6,268   43.9 %   47.3 %   $ (541 )   -8.6 %
 
 

RECONCILIATION OF NET INCOME TO NON-GAAP EBITDA AND NON-GAAP
ADJUSTED EBITDA

(In thousands, Unaudited)

 
    Three Months Ended
March 31

2019

 

2018

 
GAAP Net Income/(Loss), as reported $ (344 ) $ 374
Tax Provision/(Benefit) (138 ) 56
Depreciation and Amortization Expense 549 626
Interest Expense   115       92  
Non-GAAP EBITDA 182 1,148
Stock Compensation Expense 209 188
ASC 606 Adjustment 188
Integration Expenses 48
Inventory Recovery (2 ) (8 )
FX (Gain)/Loss   (35 )     48  
Non-GAAP Adjusted EBITDA $ 354     $ 1,612  
 

Contacts

Mike Kandell
(973) 386-9696

Or

John Nesbett
or Jen Belodeau
(203) 972 9200


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Medical Cannabis Market Report 2024-2030: Asia-Pacific Set to Witness Robust Growth, Driven by R&D Discovery Initiatives

Published

on

Continue Reading

Cannabis

Rubicon Organics Reports Q1 2024 Financial Results

Published

on

Continue Reading

SCHWAZZE

Schwazze Announces First Quarter 2024 Financial Results

Published

on

schwazze-announces-first-quarter-2024-financial-results

Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time

DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.

“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”

“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”

“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”

“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”

First Quarter 2024 Financial Summary

$ in Thousands USD

Q1 2024

Q4 2023

Q1 2023

Total Revenue

$41,601

$43,325

$40,001

Gross Profit

$17,934

$7,034[1]

$21,849

Operating Expenses

$20,643

$23,276

$16,199

Income (Loss) from Operations

$(2,709)

$(16,242)

$5,650

Adjusted EBITDA[2]

$7,341

$10,953

$14,525

Operating Cash Flow

$(3,700)

$3,452

$(880)

Recent Highlights

  • Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
  • Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
  • Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
  • Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.

First Quarter 2024 Financial Results

Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.

Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.

____________________________

1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 
2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.

Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.

Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.

As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.

Conference Call

The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars

 March 31,

December 31, 

2024

2023

 

ASSETS

 

Current Assets

Cash & Cash Equivalents

$

13,151,317

$

19,248,932

Accounts Receivable, net of Allowance for Doubtful Accounts

3,356,032

4,261,159

Inventory

26,382,184

25,787,793

Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively

108,583

456,099

Prepaid Expenses & Other Current Assets

3,502,310

3,914,064

Total Current Assets

46,500,426

53,668,047

Non-Current Assets

Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively

31,326,000

31,113,630

Investments

2,000,000

2,000,000

Investments Held for Sale

202,111

Goodwill

67,492,705

67,499,199

Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively

162,391,482

166,167,877

Other Non-Current Assets

1,328,187

1,263,837

Operating Lease Right of Use Assets

34,575,832

34,233,142

Deferred Tax Assets, net

992,144

1,996,489

Total Non-Current Assets

300,106,350

304,476,285

Total Assets

$

346,606,776

$

358,144,332

 

LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current Liabilities

Accounts Payable

$

9,443,233

$

13,341,561

Accrued Expenses

8,106,618

7,774,691

Derivative Liabilities

1,319,845

638,020

Lease Liabilities – Current

5,186,316

4,922,724

Current Portion of Long Term Debt

29,579,713

3,547,011

Income Taxes Payable

28,235,039

25,232,782

Total Current Liabilities

81,870,764

55,456,789

Non-Current Liabilities

Long Term Debt, net of Debt Discount & Issuance Costs

130,120,753

153,262,203

Lease Liabilities – Non-Current

30,735,072

30,133,452

Total Non-Current Liabilities

160,855,825

183,395,655

Total Liabilities

$

242,726,589

$

238,852,444

Stockholders’ Equity

Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and

82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of

December 31, 2023.

82

86

Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued

and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued

and 73,968,242 Shares Outstanding as of December 31, 2023.

79,169

74,888

Additional Paid-In Capital

202,677,665

202,040,968

Accumulated Deficit

(96,843,602)

(80,790,927)

Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and

920,150 Shares Held as of December 31, 2023.

(2,033,127)

(2,033,127)

Total Stockholders’ Equity

103,880,187

119,291,888

Total Liabilities & Stockholders’ Equity

$

346,606,776

$

358,144,332

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Operating Revenues

Retail

$

37,633,252

$

35,820,111

Wholesale

3,898,320

4,058,925

Other

69,421

121,900

Total Revenue

41,600,993

40,000,936

Total Cost of Goods & Services

23,667,319

18,152,163

Gross Profit

17,933,674

21,848,773

Operating Expenses

Selling, General and Administrative Expenses

11,835,818

10,100,934

Professional Services

1,671,881

1,187,364

Salaries

6,880,988

4,695,971

Stock Based Compensation

253,916

214,544

Total Operating Expenses

20,642,603

16,198,813

Income from Operations

(2,708,929)

5,649,960

Other Income (Expense)

Interest Expense, net

(8,307,369)

(7,745,854)

Unrealized Gain (Loss) on Derivative Liabilities

(681,825)

8,501,685

Other Loss

10,500

Loss on Investment

(33,382)

Unrealized Gain on Investment

(347,516)

1,816

Total Other Income (Expense)

(9,359,592)

757,647

Pre-Tax Net Income (Loss)

(12,068,521)

6,407,607

Provision for Income Taxes

3,984,154

4,662,178

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Less: Accumulated Preferred Stock Dividends for the Period

(2,155,259)

(2,029,394)

Net Income (Loss) Attributable to Common Stockholders

$

(18,207,934)

$

(283,965)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.24)

$

(0.01)

Diluted Earnings (Loss) per Share

$

(0.24)

$

(0.06)

Weighted Average Number of Shares Outstanding – Basic

76,006,932

55,835,501

Weighted Average Number of Shares Outstanding – Diluted

76,006,932

101,608,278

Comprehensive Income (Loss)

$

(16,052,675)

$

1,745,429

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(16,052,675)

$

1,745,429

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

5,096,314

6,151,395

Non-Cash Interest Expense

1,031,431

991,184

Non-Cash Lease Expense

2,871,226

2,251,459

Deferred Taxes

1,004,345

(637,225)

Loss on Investment

202,111

Change in Derivative Liabilities

681,825

(8,501,685)

Amortization of Debt Issuance Costs

421,512

421,513

Amortization of Debt Discount

2,303,246

1,999,933

(Gain) Loss on Investments, net

347,516

(1,816)

Stock Based Compensation

640,974

214,544

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

905,127

(118,181)

Inventory

(587,900)

(3,023,251)

Prepaid Expenses & Other Current Assets

411,754

(3,036,801)

Other Assets

(64,350)

360,674

Change in Operating Lease Liabilities

(2,348,703)

(1,531,765)

Accounts Payable & Other Liabilities

(3,566,401)

(3,464,671)

Income Taxes Payable

3,002,257

5,299,403

Net Cash Provided by (Used in) Operating Activities

(3,700,390)

(879,861)

Cash Flows from Investing Activities:

Collection of Notes Receivable

10,631

Purchase of Fixed Assets

(1,532,287)

(2,913,394)

Net Cash Provided by (Used in) Investing Activities

(1,532,287)

(2,902,763)

Cash Flows from Financing Activities:

Payment on Notes Payable

(864,938)

Net Cash Provided by (Used in) Financing Activities

(864,938)

Net (Decrease) in Cash & Cash Equivalents

(6,097,615)

(3,782,624)

Cash & Cash Equivalents at Beginning of Period

19,248,932

38,949,253

Cash & Cash Equivalents at End of Period

$

13,151,317

$

35,166,628

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

4,515,205

$

6,540,748

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Interest Expense, net

8,307,369

7,745,854

Provision for Income Taxes

3,984,154

4,662,178

Other (Income) Expense, net of Interest Expense

1,052,223

(8,503,501)

Depreciation & Amortization

5,618,834

6,612,814

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

2,909,905

$

12,262,774

Non-Cash Stock Compensation

253,916

214,544

Deal Related Expenses

637,761

1,195,802

Capital Raise Related Expenses

20,760

35,068

Severance

484,561

118,436

Retention Program Expenses

807,500

280,632

Pre-Operating & Dark Carry Expenses

1,053,837

391,917

One-Time Legal Settlements

417,653

Other Non-Recurring Items

754,751

25,707

Adjusted EBITDA (non-GAAP)

$

7,340,644

$

14,524,880

Revenue

41,600,993

40,000,936

Adjusted EBITDA Percent

17.6 %

36.3 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania